Digital therapies are proving particularly useful in pathological conditions linked to behavioural and psychological factors, such as Alzheimer’s, dementia, type II diabetes, and even serious respiratory problems. Let’s take a look at how they are made, how they work, the indications and market perspectives.
Google Health presented the Electronic Health Record (EHR) that it is developing as part of a new generation of digital clinical instruments. It represents a difficult and very demanding challenge for industry players. Continue reading →
The market for remote monitoring solutions sees the entry of large companies offering B2B solutions. What impact will this phenomenon have on a sector that until now has been the prerogative of small and medium-sized companies? Continue reading →
According to Rock Health, after a first half in which companies raised over $2 billion each quarter, Q3 2019 saw funding of $1.3 billion, a total of $5.5 billion since the start of the year. Continue reading →
Babylon announced a record investment of $550 million, bringing the company’s value to over $2 billion, to fund the development of new solutions for the treatment of chronic diseases and international expansion in the United States and Asia. Continue reading →